Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)-Gene Rearrangements. (2021)

First Author: Tsakaneli A
Attributed to:  Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2021.741413

PubMed Identifier: 34594227

Publication URI: http://europepmc.org/abstract/MED/34594227

Type: Journal Article/Review

Volume: 12

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812